Lorrain Daniel S.'s Form 4 filing
Contineum Therapeutics, Inc. (CTNM) · filed Jul 10, 2026
- Accession no.
- 0001628280-26-047909
- Filed
- Jul 10, 2026, 5:20 PM ET
- Trade date
- Jul 8-9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $16.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lorrain Daniel S.CIK 0001861550 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Class A Common Stock | MOption exerciseAcquired | +1,015 | $1.01 | +$1,025.15 | 136,217 | Direct | |
| Jul 8, 2026 | Class A Common Stock | SSaleDisposed | −1,015 | $16.00 | −$16,240 | 135,202 | Direct | |
| Jul 9, 2026 | Class A Common Stock | MOption exerciseAcquired | +25 | $1.01 | +$25.25 | 135,227 | Direct | |
| Jul 9, 2026 | Class A Common Stock | SSaleDisposed | −25 | $16.00 | −$400 | 135,202 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Class A Common Stock | MOption exerciseDisposed | −1,015 | $0.00 | $0 | 33,282 | Direct | |
| Jul 9, 2026 | Class A Common Stock | MOption exerciseDisposed | −25 | $0.00 | $0 | 33,257 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.